共 212 条
[11]
Kameda Y(2011)Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension Hypertension 57 413-421
[12]
Kubota A(2017)Comparison of efficacy and safety of azilsartan and olmesartan in patients with essential hypertension Int Heart J 58 416-67
[13]
Kobayashi Y(2017)Practical efficacy of olmesartan versus azilsartan in patients with hypertension: a multicenter randomized-controlled trial (MUSCAT-4 study) Blood Press Monit 22 59-167
[14]
Komuro I(2016)Changeover trial of azilsartan and olmesartan comparing effects on the renin-angiotensin-aldosterone system in patients with essential hypertension after cardiac surgery (CHAOS study) Ann Thorac Cardiovasc Surg 22 161-88
[15]
Georgiopoulos G(2011)The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure J Clin Hypertens 13 81-117
[16]
Katsi V(2017)A meta-analysis of add-on use of spironolactone in patients with resistant hypertension Int J Cardiol 233 113-12
[17]
Oikonomou D(1996)Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1-560
[18]
Vamvakou G(2003)Measuring inconsistency in metaanalyses BMJ 327 557-1101
[19]
Koutli E(1994)Operating characteristics of a rank correlation test for publication bias Biometrics 50 1088-1223
[20]
Laina A(2016)The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements J Hypertens 34 1218-3008